TLC is dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and improve efficacy.
TLC is dedicated to the research, development, and commercialization of best-in-class novel lipid nanoparticle (LNP)-based medicines
Platforms to create drugs that are longer lasting with increased efficacy, and enabling new mechanisms that would otherwise be impractical
TLC has a robust pipeline of early- to late-stage programs in the areas of pain management, ophthalmology, and oncology.
At TLC, you can make a difference with your professional interests while maintaining a great work-life balance!Learn More